Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
67,931.11 +2,220.55 (+3.38%) CMC Crypto 200
1,375.16 +44.56 (+3.35%)
NVO Jan 2026 150.000 put
| Previous close | 22.88 |
| Open | 22.75 |
| Bid | 29.75 |
| Ask | 30.65 |
| Strike | 150.00 |
| Expiry date | 2026-01-16 |
| Day's range | 22.75 - 22.88 |
| Contract range | N/A |
| Volume | |
| Open interest | 284 |
- Yahoo Finance Video
June PCE inflation print, auto earnings: Morning Brief
The Federal Reserve's preferred inflation gauge, the Personal Consumption Expenditures (PCE) index, showed prices rising at its slowest rate in over three years while core PCE data came largely in-line with expectations. Seana Smith and Jared Blikre help investors start the day off right, highlighting the biggest market stories this morning as the three major averages (^DJI, ^IXIC, ^GSPC) digest the June PCE print. Bank of America Securities head of US economics Michael Gapen joins the program to shine a light on how the Fed may be looking at the June PCE data, alongside other recent inflation prints, in terms of its interest rate cut strategy. Bernstein senior analyst Daniel Roeska also sits down with The Morning Brief team to cover the auto industry's earnings performance this week, including Tesla (TSLA) and Stellantis (STLA). Other top trending tickers on the Yahoo Finance platform include the 3M Company (MMM), Deckers Outdoor (DECK), DexCom (DXCM), Norfolk Southern (NSC), and Coursera (COUR). This post was written by Luke Carberry Mogan.
- Yahoo Finance Video
EU approves Novo Nordisk's Wegovy for heart, stroke treatment
Novo Nordisk's (NVO) weight-loss drug Wegovy received the approval of European Union (EU) regulators to use the GLP-1 to treat heart issues and reduce stroke risks. Anjalee Khemlani explains the details of Novo Nordisk's data on this treatment method. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
ZacksIs Eli Lilly's Stock in a Bubble?
Shares of Eli Lilly are up 150% over the last 2 years as investors are bullish about the new weight loss drugs. Is it too hot to handle?
